SEC Form D private-offering filing

CoRegen, Inc.

A new SEC Form D private-offering notice from Houston, TX, a $13,500,000 filer-stated offering target in Biotech. The source filing is one click away.

CoRegen, Inc. site↗ Verified via SEC Form D

Houston, TX biopharmaceutical company developing an adoptive cell therapy platform that engineers regulatory T cells to target solid tumor cancers, licensed from Baylor College of Medicine.

Filed 2026-02-26Filed to raise $13,500,000First money in 2025-10-28Raised so far $13,500,000HQ (as filed) Houston, TXSector Biotech ✓Stage (inferred) EarlyCall status Late filing
Source linked the Form D on EDGAR↗Website verified coregen.com↗Named in the filing 10 executives & directors
Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.